Table 4 5-year survival for different demographic groups of AML patients with t(3;3) /inv(3).
Groups | 5- Year OS (%, 95%CI) | 5-Year CSS (%, 95%CI) |
|---|---|---|
Overall | 15.29 (7.98–24.78) | 20.05(10.69–31.51) |
Age | ||
<60 years | 36.65 (19.23–54.28) | 38.18(20.09–56.1) |
≥60 years | 0 | 0 |
Sex | ||
Female | 14.07 (5.26–27.09) | 17.35(6.56–32.43) |
Male | 17.35 (6.74–32.06) | 24.40(9.93–42.25) |
Diagnosis year | ||
2010–2015 | 11.11 (3.52–23.62) | 13.47(4.38–27.68) |
2016–2021 | 19.64 (8.32–34.45) | 27.44(11.90-25.58) |
Marital status at diagnosis | ||
Married (including common law) | 14.56 (5.76–27.24) | 20.89(8.47–37.05) |
Single (never married) | 42.21 (15.55–67.05) | 46.90(17.53–71.94) |
Divorced | 0 | 0 |
Widowed | 0 | 0 |
Unknown | 0 | 0 |
Race and Ethnicity | ||
Hispanic (all races) | 22.22 (3.37–51.31) | 22.22(3.37–51.31) |
Non-Hispanic White | 16.93 (8.42–27.96) | 21.11(10.69–33.90) |
Non-Hispanic Black | 0 | 0 |
Non-Hispanic Asian or Pacific Islander | 0 | 0 |
Non-Hispanic American Indian/Alaska Native | 0 | 0 |
Median household income | ||
<$75,000 | 17.36 (6.09–33.43) | 20.16(7.23–37.66) |
≥$75,000 | 13.98 (5.55–26.20) | 19.86(8.09–35.39) |
Chemotherapy | ||
Yes | 17.61 (9.27–28.12) | 21.54(11.56–33.53) |
No/Unknown | 0 | 0 |
PRCDA | ||
PRCDA | 17.45 (6.13–33.58) | 20.82(7.32–38.99) |
Not PRCDA | 13.77 (5.41–25.98) | 20.00(8.27–35.37) |
Rural-Urban Continuum Code | ||
Counties in metropolitan areas ge 1 million pop | 13.70 (5.07–26.59) | 20.97(8.03–38.01) |
Counties in metropolitan areas of 250,000 to 1 million pop | 5.00 (0.35–20.53) | 6.00(0.42–23.60) |
Counties in metropolitan areas of lt 250 thousand pop | 0 | 0 |
Nonmetropolitan counties adjacent to a metropolitan area | 43.75 (10.14–74.19) | 58.33(18.02–84.41) |
Nonmetropolitan counties not adjacent to a metropolitan area | 0 | 0 |
